1.Autophagy in Innate Recognition of Pathogens and Adaptive Immunity.
Yonsei Medical Journal 2012;53(2):241-247
Autophagy is a specialized cellular pathway involved in maintaining homeostasis by degrading long-lived cellular proteins and organelles. Recent studies have demonstrated that autophagy is utilized by immune systems to protect host cells from invading pathogens and regulate uncontrolled immune responses. During pathogen recognition, induction of autophagy by pattern recognition receptors leads to the promotion or inhibition of consequent signaling pathways. Furthermore, autophagy plays a role in the delivery of pathogen signatures in order to promote the recognition thereof by pattern recognition receptors. In addition to innate recognition, autophagy has been shown to facilitate MHC class II presentation of intracellular antigens to activate CD4 T cells. In this review, we describe the roles of autophagy in innate recognition of pathogens and adaptive immunity, such as antigen presentation, as well as the clinical relevance of autophagy in the treatment of human diseases.
Adaptive Immunity/immunology/*physiology
;
Animals
;
Antigen Presentation/immunology/physiology
;
Autophagy/immunology/*physiology
;
Humans
;
Major Histocompatibility Complex/immunology/physiology
2.Discovery of MHC restriction in antigen recognition of T cells.
Gong-tao LAN ; Li-ping ZHU ; Wei ZHANG
Acta Academiae Medicinae Sinicae 2002;24(5):539-541
T cell can only recognize specific antigenic peptide-MHC complex on antigen-presenting cell. This is MHC restriction in antigen recognition of T cell. This phenomenon was discovered by an Austrian scientist Peter. C. Doherty and a Swedish scientist Rolf. M. Zinkernagel by chance. Then, in order to explain the phenomenon, they proposed two hypotheses: dual receptor and modified self. In the during following 20 years numbers of scientists spent great amount of time in the study of the phenomenon. The process of cell-mediated immune response becomes clear, which greatly promotes the advancing of immunology and many related disciplines.
Animals
;
Antigen-Presenting Cells
;
immunology
;
Epitopes
;
immunology
;
Humans
;
Immunity, Cellular
;
Major Histocompatibility Complex
;
immunology
;
Receptors, Antigen, T-Cell
;
immunology
;
T-Lymphocytes
;
immunology
3.Heterologous corneal endothelial cell transplantation: human corneal endothelial cell transplantation in Lewis rats.
Journal of Korean Medical Science 1992;7(4):337-342
A heterologous corneal endothelial transplantation was attempted using human endothelial cells and a Lewis rat penetrating keratoplasty model. Cultured human endothelial cells were seeded to a Lewis rat cornea, which was denuded of its endothelium. When grafted into the syngeneic Lewis rat, the graft remained clear for at least five days, and then became opaque and edematous because of immune rejection reaction. In contrast, corneas denuded of their endothelium became opaque and edematous immediately after transplantation. These results demonstrate that transplanted endothelial cells have enough antigens to induce rejection reaction even though they have the functional capacity to deturge the cornea.
Animals
;
Endothelium, Corneal/cytology/immunology/*transplantation
;
Female
;
Graft Rejection/*immunology
;
Humans
;
Major Histocompatibility Complex/immunology
;
Rats
;
Rats, Inbred Lew
;
Transplantation, Heterologous
4.Donor MHC gene to mitigate rejection of transplantation in recipient mice.
Tong LI ; Jun YAN ; Jia-Li TAN ; Yue-Ping LÜ ; Sheng-Cai HOU ; Shen-Tao LI ; Qing XU ; Xue-Hong TONG ; Jie DING ; Zhi-Tai ZHANG ; Hui LI
Chinese Medical Journal 2011;124(24):4279-4285
BACKGROUNDDonor organ rejection continues to be a significant problem for patients receiving transplants. We therefore tested whether transferring a donor's major histocompatibility complex (MHC) gene to the recipient would mitigate the rejection of transplanted hearts in mice.
METHODSH-2K(k) gene from donor mice was amplified using nested polymerase chain reaction (PCR) and ligated into a mammalian expression vector, which was then transfected into thymus ground mass cells collected from the recipients. Clones stably expressing the transgene were then injected into the recipients' thymus visualized using ultrasound. Control mice were administered cells previously transfected with empty vector. Following heart transplantation, cardiac activity was monitored electrocardiographically. Recipient thymus cells were tested for MHC antigenicity using flow cytometry and spleen cells were subjected to mixed lymphocyte culture tests. Finally, the transplanted hearts were sectioned, stained and examined under light microscopy.
RESULTSSouthern analysis following nested PCR revealed clear expression of H-2K(k) gene. Following transplantation, electrocardiosignals were detectable highly significantly longer in recipients administered thymal cells expressing donor H-2K(k) than in those receiving control cells. Flow cytometric analysis using an anti-H-2K(k) antibody confirmed its expression in H-2K(k) treated recipients but not in control mice. Mixed lymphocyte cultures containing H-2K(k) treated cells showed significantly less proliferation than those containing control cells. Hearts from control mice showed substantially greater lymphocyte infiltration than those from H-2K(k) treated mice and large areas of necrosis.
CONCLUSIONRejection of transplanted hearts can be mitigated substantially by introducing the donor's MHC into the recipient.
Animals ; Blotting, Southern ; Electrocardiography ; Female ; Flow Cytometry ; Graft Rejection ; genetics ; immunology ; Heart Transplantation ; immunology ; methods ; Major Histocompatibility Complex ; genetics ; immunology ; Male ; Mice ; Polymerase Chain Reaction
6.KIR and allogeneic hematopoietic cell transplantation - review.
Journal of Experimental Hematology 2004;12(1):108-114
The profound graft-versus-leukemia (GVL) effect presented after allogeneic hematopoietic cell transplantation (allo-HSCT) has been evidenced. In contrast to T cell mediated GVL, natural killer (NK) cells recognize target cells and introduce GVL effect by using an integration of activating and inhibitory receptors. This review has summarized current literatures from 2001 - 2003 on human killer cell immunoglobulin receptors (KIR) and other NK cell receptors involved in recognition of tumor targets and the polymorphism of KIR genes of donor/recipient pairs of related and unrelated Allo-HSCT. KIR epitope mismatch may facilitate engraftment and reduce leukemia relapse post transplant by mediating lysis of recipient's cells and introducing GVL effect under the condition of KIR epitope mismatch. Clinical roles of KIR in Allo-HSCT and immunotherapy are discussed. Technologic approach in allogeneic reactive NK cells introduction, identification and selection in vitro, development of inhibitory receptor blockade as well as up-regulation of activating NK cells may significantly enhance GVL immune response. Further investigation on the regulation of KIR inhibitory receptors enables to design novel strategy in cancer immunotherapy over the forthcoming decade.
Graft vs Host Disease
;
immunology
;
Hematopoietic Stem Cell Transplantation
;
Humans
;
Immune Tolerance
;
Killer Cells, Natural
;
immunology
;
Major Histocompatibility Complex
;
Receptors, Immunologic
;
chemistry
;
genetics
;
physiology
;
Receptors, KIR
;
Transplantation, Homologous
7.Effect of CD8(+)CD28(-) suppressor T cells induced by dendritic cell with major histocompatibility complex 1 expression RNA interference on immune tolerance in rat intestinal transplantation.
Li-jun XUE ; Lu YIN ; Chun-qiu CHEN ; Gui-yang ZHANG ; Fang-jun WAN ; Zhi-ming JIN ; Jun-sheng NI
Chinese Journal of Gastrointestinal Surgery 2009;12(4):404-408
OBJECTIVETo investigate the effect of CD8(+)CD28(-) suppressor T cells(Ts) induced by dendritic cell(DC) with major histocompatibility complex 1(MHC-1) expression RNA interference on immune tolerance in rat intestinal transplantation.
METHODSThe expression level of CD8(+)CD28(-)Ts were successfully induced by DC with MHC-1 expression interfered by RNA interference technique under the stimulator of allograft antigen. Orthotopic intestinal transplantation was performed in 36 rats by modified three cuffs method. The recipients were randomly divided into three groups(12 rats in each group):group A was experimental group with CD8(+)CD28(-) Ts being administrated, mixed T cells were injected in group B, while in group C, NS were administrated. On the first day and the seventh day posttransplant, the 36 rats of the 3 groups were administrated through vena dorsalis penis respectively. Six rats were selected randomly from each group and the animals were sacrificed on the 14 th day postoperatively, serum levels of TGF-beta, IFN-gamma and the values of Na(+)-K(+)-ATPase activity of the intestinal graft were assayed and the intestinal pathologic morphology, intestinal allograft survival were observed concerning the remainders.
RESULTSOn the 14 th day after operation, the expression levels of TGF-beta and IFN-gamma in group A were significantly up-regulated as compared with those in group B and group C(P<0.05). Na(+)-K(+)-ATPase activity in group A was(6.3+/-1.0) kU/g, much higher than the levels of group B(3.6+/-0.9)kU/g and group C(2.9+/-1.3) kU/g and the differences were significant(P<0.05). The data suggested preliminarily that pathological scores of intestinal graft in group A were lower than those in group B and group C. The survival time of the recipients in group A was 32.0 days, much longer than that in group B (17.5 days, P<0.05) and group C(21.0 days, P<0.05).
CONCLUSIONCD8(+)CD28(-) Ts induced by DC with MHC-1 expression RNA interference can alleviate acute rejection and lead to immune tolerance in rat intestinal transplantation.
Animals ; Dendritic Cells ; immunology ; metabolism ; Immune Tolerance ; Intestine, Small ; immunology ; transplantation ; Major Histocompatibility Complex ; immunology ; Male ; RNA Interference ; Rats ; Rats, Sprague-Dawley ; Rats, Wistar ; T-Lymphocytes, Regulatory ; immunology ; Transplantation Tolerance ; immunology ; Transplantation, Homologous ; immunology
8.Relationships among immune traits and MHC B-LBII genetic variation in three chicken breeds.
Fuwei LI ; Shuqing LI ; Yan LU ; Qiuxia LEI ; Haixia HAN ; Yan ZHOU ; Bin WU ; Dingguo CAO
Chinese Journal of Biotechnology 2013;29(7):904-913
We have assessed the relationships between immune trait (antibody titers of Sheep red blood cell, SRBC; Avian influenza, AI; Newcastle disease, ND) and varieties of MHC B-LBHII Gene in local chicken breeds (Wenshang Barred chicken, LH; Laiwu Black chicken, LWH; and Jining Bairi chicken, BR). We selected 300 chickens randomly from the three indigenous chicken populations. The variations of MHC B-L BII gene were detected by directly DNA sequencing and polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP). The results indicated that there were about 19-22 nucleotide mutations in the three local breeds, which could affect 16-18 amino acid variations. Another results indicated that there was significantly relationship between seven to eight SNPs of the MHC B-LBII region and some immune traits (P < 0.05 or P < 0.01). Both locus G97A and locus T138A were found in the three species, which were significantly related to the antibodies of SRBC, ND and AI antibody titers (P < 0.05). Among them, the locus G97A was significantly associated with ND antibody titers (P < 0.05) in BR chicken, with SRBC antibody titers (P < 0.05) in LWH chicken, and with H9 antibody titers (P < 0.05) in LH chicken. Furthermore, locus T138A was significantly associated with H9 antibody titers in BR and LH chickens (P < 0.05). All those results suggest relationships among the different varieties of MHC B-LBII and immune traits in the three local breeds.
Animals
;
Base Sequence
;
Breeding
;
Chickens
;
genetics
;
immunology
;
Major Histocompatibility Complex
;
genetics
;
Polymerase Chain Reaction
;
Polymorphism, Single Nucleotide
;
Polymorphism, Single-Stranded Conformational
;
Sequence Analysis, DNA
9.Comparative study of the immunological characteristics of three different C57BL/6N mouse substrains.
Jun Young CHOI ; Hye Ryeong KIM ; Kil Soo KIM ; Young Suk JUNG ; Joon Young CHO ; Dae Youn HWANG ; Hyun Keun SONG
Laboratory Animal Research 2017;33(2):124-131
Inbred mice, a systematically developed homogeneous animal, have been developed to maintain experimental reproducibility and to minimize experimental variables in animal-based studies. In particular, C57BL/6 mice are frequently used in experiments into immunology and antitumor activity experiments. This study was compared the immunological characteristics of C57BL/6NKorl, a Korean developed experimental animal resource, with those of two other C57BL/6N substrains. Mouse body, thymus, and spleen weights in C57BL/6NKorl were not significantly different from those of the other two C57BL/6N substrains. Among the three substrains, there was no difference in the distribution of T and B cells, which are lymphocytes involved in adaptive immunity, and no difference in NK cells related to innate immunity. Results for macrophages and granulocytes, which have roles in innate immunity, were similar in all three substrains. In order to investigate the expressions of major histocompatibility complex (MHC) molecules and allogenic antigens, splenocytes were separated from obtained spleen and analyzed by using flow cytometry. MHC class I and II molecules, which are important during self/non-self-discrimination, were similar in the three substrains. In addition, expression of alloantigen involved in allografts showed similar results in the three substrain. Thus, the results of this study provide strong evidence that C57BL/6NKorl is immunologically similar to two other C57BL/6N substrains.
Adaptive Immunity
;
Allergy and Immunology
;
Allografts
;
Animals
;
B-Lymphocytes
;
Flow Cytometry
;
Granulocytes
;
Immunity, Innate
;
Isoantigens
;
Killer Cells, Natural
;
Lymphocytes
;
Macrophages
;
Major Histocompatibility Complex
;
Mice*
;
Spleen
;
Thymus Gland
;
Weights and Measures
10.Advances in the study of molecular mechanisms, applications and screening for altered peptide ligand.
Qing-Qing WANG ; Hong-Zhen YANG ; Zhuo-Wei HU
Acta Pharmaceutica Sinica 2008;43(2):113-117
Altered peptide ligand (APL), a short peptide with immune regulatory activity and substitutions of a single or multiple amino acids in an antigenic peptide, has shown potential therapeutic effect on autoimmune disease, tumor and virus infection. APL regulates immune responses by interfering the interaction between the major histocompatibility complex (MHC), antigenic peptide and T cell receptor (TCR), or by regulating the intracellular signaling of antigen presenting cells, bystander suppression and inducing heterogenous immune responses. High-specific and high-affinity APL screened from peptide laboratory by phage display, has a potential to be a new resource for drug with antigen specificity.
Animals
;
Antigen-Presenting Cells
;
immunology
;
metabolism
;
Autoimmune Diseases
;
immunology
;
therapy
;
Humans
;
Immunotherapy
;
methods
;
Ligands
;
Major Histocompatibility Complex
;
immunology
;
Peptide Fragments
;
biosynthesis
;
immunology
;
metabolism
;
therapeutic use
;
Peptide Library
;
Receptors, Antigen, T-Cell
;
immunology
;
metabolism